AN2 Therapeutics, Inc. (ANTX)
4.74
-0.06
(-1.25%)
USD |
NASDAQ |
Apr 28, 16:00
4.73
-0.01
(-0.21%)
After-Hours: 20:00
AN2 Therapeutics Market Cap : 170.36M for April 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Relmada Therapeutics, Inc. | 759.40M |
| ACADIA Pharmaceuticals, Inc. | 3.865B |
| Alnylam Pharmaceuticals, Inc. | 40.07B |
| Savara, Inc. | 1.027B |
| BioMarin Pharmaceutical, Inc. | 10.25B |
Market Cap Related Metrics
| Price to Book Value | 3.211 |
| Price | 4.74 |
| Earnings Yield | -24.56% |